Apogee Therapeutics, Inc. (APGE) News
Track canonical SquawkNews coverage tagged to APGE, Apogee Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 19 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
() -- Biopharma sector's performance in H2 is expected to be driven more by company fundamentals rather than macroeconomic factors, Morgan Stanley said in a note Tuesday. As of July 6, the NYSE Arca Pharmaceutical Index
RATES | Jul 08, 2026, 03:11 PM UTC
M
Analysts Raise Targets
Top Wall Street analysts raise price targets for several stocks including Okta, International Seaways, and Ralliant
EQUITY | Jun 24, 2026, 01:00 PM UTC
H
AbbVie Acquires Apogee
AbbVie acquires Apogee Therapeutics in a $10.9 billion cash deal, expanding its immunology pipeline
EQUITY | Jun 23, 2026, 05:13 PM UTC
M
Citi Downgrades APGE
Citi downgrades APGE to Neutral, while other firms issue ratings on DRI, NKE, PRIM, ROST, SBRA, TLN, and ZION
EQUITY | Jun 23, 2026, 10:55 AM UTC
M
Healthcare Stocks Moving
Multiple healthcare stocks are moving in Monday's intraday session, with gainers including Tenon Medical and Aditxt, and losers including Aethlon Medical and Atlantic International
EQUITY | Jun 22, 2026, 05:23 PM UTC
H
DFTX +65% on Phase 3 Results
DFTX shares rise 65% on positive topline results from Phase 3 Emerge Study of DT120
EQUITY | Jun 22, 2026, 01:17 PM UTC
H
APGE +45% on Acquisition
AbbVie to acquire Apogee Therapeutics, sending APGE stock up 45% premarket
EQUITY | Jun 22, 2026, 12:21 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Monday's pre-market session, with gains and losses across the sector
EQUITY | Jun 22, 2026, 12:08 PM UTC
M
APGE: Trading Halt
APGE trading halted, quotation resumption pending
EQUITY | Jun 22, 2026, 11:15 AM UTC
H
ABBV Acquires APGE
AbbVie is acquiring Apogee for $135.11 per share in cash to expand its pipeline of clinical-stage candidates for inflammatory and immunological diseases
EQUITY | Jun 22, 2026, 11:05 AM UTC
H
ABBV Acquires APGE
AbbVie is acquiring Apogee Therapeutics to deepen its immunology portfolio
EQUITY | Jun 22, 2026, 11:03 AM UTC
M
GETY Leads Premarket Gainers
GETY and other stocks are leading premarket gainers, while AIXI and others are among the biggest losers
EQUITY | Jun 22, 2026, 10:58 AM UTC
H
SAGT Surges 76%
Sagtec Global shares rise 75.6% in pre-market trading after issuing financial year 2026 guidance projecting 35% revenue growth
EQUITY | Jun 22, 2026, 09:23 AM UTC
H
ABBV to Acquire APGE
AbbVie is closing in on a nearly $11 billion deal to acquire biotech company Apogee Therapeutics
EQUITY | Jun 22, 2026, 08:25 AM UTC
H
ABBV to Buy APGE
AbbVie is closing in on a nearly $11 billion deal to buy Apogee Therapeutics
EQUITY | Jun 19, 2026, 02:38 PM UTC